Investigation Report on China's Insulin Aspart Market, 2018-2022

Publisher Name :
Date: 01-Nov-2018
No. of pages: 30

Description

The rapid development of the Chinese economy in the past three decades has changed people's dietary habits and reduced physical activities, which leads to an increasing incidence of obesity-related diseases. It is estimated that at the end of 2017, there were more than 100 million diabetic patients in China. The market size of diabetes drugs is also growing in China.

On Dec. 26, 2001, Novo Nordisk announced that Insulin Aspart (trade name: NovoRapid), the first and only insulin analog that can be used with insulin pumps, was approved by the FDA. Insulin Aspart starts working in 10 to 20 minutes after subcutaneous injection and can reduce postprandial blood glucose and glycated hemoglobin (HbA1c). On the basis of Insulin Aspart, Novo Nordisk developed premixed insulin aspart containing soluble insulin aspart and protaminated insulin aspart of various proportions. The combination of the fast-acting form and the long-acting form allows patients to receive fewer injections over the course of the day. NovoLog Mix 70/30, containing 30% soluble insulin aspart and 70% protaminated insulin aspart, was approved by the FDA in Nov. 2001. Similar NovoLog Mix 50/50 was approved by the FDA in Aug. 2008. In Apr. 2005, NovoMix 30 (30% soluble insulin aspart and 70% protaminated insulin aspart), the first premixed insulin analog, was launched in China. According to CRI, from 2005 to 2017, the sales value of Insulin Aspart in China grew by over 100 times. The market size of Insulin Aspart in China exceeded CNY 200 million in 2017.

Because there are high technical barriers against the imitation of Insulin Aspart, by Oct. 2018, China's Insulin Aspart market is monopolized by Novo Nordisk's Insulin Aspart (NovoRapid). According to CRI, several Chinese companies are applying for the CFDA's approval for generic Insulin Aspart. However, the launch of generic drugs will take several years. With an increasing number of diabetic patients, the market size of Insulin Aspart in China will maintain rapid growth in the next few years.

Topics Covered:


  • Situation of diabetes in China

  • Sales of Insulin Aspart in China

  • Prices of Insulin Aspart in China

  • Progress of generic Insulin Aspart in China

  • Prospect of China's Insulin Aspart market from 2018 to 2022

Investigation Report on China's Insulin Aspart Market, 2018-2022

Table of Contents

1 Relevant Concepts of Insulin Aspart
1.1 Indications for Insulin Aspart
1.2 Development of Insulin Aspart in China
1.3 Patents and Government Approval on Insulin Aspart in China

2 Sales of Insulin Aspart in China, 2013-2017
2.1 Sales Value of Insulin Aspart
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Insulin Aspart
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Insulin Aspart by Dosage Form in China, 2013-2017

3 Analysis on Major Insulin Aspart Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Insulin Aspart Manufacturers
3.2 Novo Nordisk
3.2.1 Enterprise Profile
3.2.2 Sales of Novo Nordisk's Insulin Aspart in China

4 Prices of Insulin Aspart in China, 2017-2018
4.1 Novo Nordisk (NovoRapid)
4.2 Progress of Generic Drugs

5 Prospect of China's Insulin Aspart Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

List of Charts

Chart Sales of Insulin Aspart in China, 2013-2017
Chart Sales Value of Insulin Aspart in Parts of China, 2013-2017
Chart Sales Volume of Insulin Aspart in China, 2013-2017
Chart Sales Volume of Insulin Aspart in Parts of China, 2013-2017
Chart Sales Value of Insulin Aspart Injections in China, 2013-2017
Chart Sales Volume of Insulin Aspart Injections in China, 2013-2017
Chart Sales Value of Novo Nordisk's Insulin Aspart (NovoRapid), 2013-2017
Chart Sales Volume of Novo Nordisk's Insulin Aspart (NovoRapid), 2013-2017
Chart Prices of Novo Nordisk's Insulin Aspart (NovoRapid) in Parts of China in 2017

  • Global Insulin Glargine Market Research Report 2012-2024
    Published: 17-Jul-2019        Price: US 1800 Onwards        Pages: 81
    Summary Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). The global Insulin Glargine market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The......
  • Global Insulin Lispro Market Research Report 2012-2024
    Published: 17-Jul-2019        Price: US 1800 Onwards        Pages: 86
    Summary Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline in the beta chain of the insulin polypeptide. The global Insulin Lispro market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to de......
  • Global Insulin Market Research Report 2012-2024
    Published: 17-Jul-2019        Price: US 3040 Onwards        Pages: 104
    Summary Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose productio......
  • Diabetes Drugs-Global Market Status and Trend Report 2014-2026
    Published: 15-Jul-2019        Price: US 2480 Onwards        Pages: 142
    Report Summary Diabetes Drugs-Global Market Status and Trend Report 2014-2026 offers a comprehensive analysis on Diabetes Drugs industry, standing on the readers' perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include: Worldwide and Regional Market Size of Diabetes Drugs 2014-2019......
  • Diabetes Drugs-Global Market Status & Trend Report 2014-2026 Top 20 Countries Data
    Published: 15-Jul-2019        Price: US 3680 Onwards        Pages: 148
    Report Summary Diabetes Drugs-Global Market Status & Trend Report 2014-2026 Top 20 Countries Data offers a comprehensive analysis on Diabetes Drugs industry, standing on the readers' perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include: Worldwide and......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2012-2024
    Published: 13-Jul-2019        Price: US 2390 Onwards        Pages: 87
    Summary Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia. The global Glucagon Like Peptide-1 (GLP-1) Agonists market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment......
  • Global Insulin Drugs Diabetes Therapeutics Industry Market Research Report
    Published: 11-Jul-2019        Price: US 2960 Onwards        Pages: 118
    The Insulin Drugs Diabetes Therapeutics market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Insulin Drugs Diabetes Therapeutics industrial chain, this report mainly elaborates the definition, types, applications and major players of Insulin Drugs Diabetes Therapeutics market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages ......
  • Global Insulin Glargine Industry Market Research Report
    Published: 11-Jul-2019        Price: US 2960 Onwards        Pages: 123
    The Insulin Glargine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Insulin Glargine industrial chain, this report mainly elaborates the definition, types, applications and major players of Insulin Glargine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry develo......
  • Global Meglitinides Industry Market Research Report
    Published: 11-Jul-2019        Price: US 2960 Onwards        Pages: 127
    The Meglitinides market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Meglitinides industrial chain, this report mainly elaborates the definition, types, applications and major players of Meglitinides market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs